Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-23-062887
Filing Date
2023-11-13
Accepted
2023-11-13 16:00:09
Documents
1
Period of Report
2023-10-31

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 5091
  Complete submission text file 0000950170-23-062887.txt   7222
Mailing Address C/O FORBION CAPITAL PARTNERS GOOIMEER 2-35 NAARDEN P7 1411DC
Business Address C/O FORBION CAPITAL PARTNERS GOOIMEER 2-35 NAARDEN P7 1411DC 31 35 6993000
Forbion Capital Fund III Cooperatief U.A. (Reporting) CIK: 0001747586 (see all company filings)

State of Incorp.: P7 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41854 | Film No.: 231398368

Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Issuer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address GOOIMEER 2-35 NAARDEN P7 1411DC
Business Address GOOIMEER 2-35 NAARDEN P7 1411DC 31356993015
Forbion III Management B.V. (Reporting) CIK: 0002000415 (see all company filings)

State of Incorp.: P7 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41854 | Film No.: 231398367